January 30, 2019
Phase 3 Study of Sofosbuvir and Ribavirin
Read More
January 30, 2019
Phase 3 Study of Sofosbuvir and Ribavirin
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks…
Read More
January 30, 2019
SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks…
Read More
January 30, 2019
A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b…
Read More
January 30, 2019
Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B…
Read More
January 30, 2019
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With…
Read More
January 30, 2019
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With…
Read More
January 30, 2019
Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B…
Read More
December 10, 2018
Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. APL-2 in&hellip...
Read More